Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant

Blood

Volumn 104, Issue 10, 2004, Pages 3386-3392

  Syrjala, Karen L ^a   Dikmen, Sureyya ^b   Langer, Shelby L ^b   Roth Roemer, Sari ^b   Abrams, Janet R ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GLUCOCORTICOID; HYDROXYUREA; INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GRIP STRENGTH; HUMAN; HUMAN EXPERIMENT; LOGISTIC REGRESSION ANALYSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEMORY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MULTIPLE MYELOMA; MYELODYSPLASIA; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TREATMENT OUTCOME; VERBAL COMMUNICATION;

EID: 8644225828     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-1155     Document Type: Article

References (27)

1. Ahles TA, Tope DM, Furstenberg C, Hann D, Mills L. Psychologic and neuropsychologic impact of autologous bone marrow transplantation. J Clin Oncol. 1996;14:1457-1462.
2. Harder H, Cornelissen JJ, Van Gool AR, Duivenvoorden HJ, Eijkenboom WM, van den Bent MJ. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer. 2002;95:183-192.
3. Peper M, Steinvorth S, Schraube P, et al. Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors. Int J Radiat Oncol Biol Phys. 2000;46:303-311.
4. van Dam FS, Schagen SB, Muller MJ, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst. 1998;90:210-218.
5. Wenz F, Steinvorth S, Lohr F, et al. Prospective evaluation of delayed central nervous system [CNS] toxicity of hyperfractionated total body irradiation [TBI]. Int J Radiat Oncol Biol Phys. 2000;48:1497-1501.
6. Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D. Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol. 1994;12:820-826.
7. Parth P, Dunlap WP, Kennedy RS, Lane NE, Chapman CR, Ordy JM. Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy. Percept Mot Skills. 1989;68:1227-1241.
8. Bartynski WS, Grabb BC, Zeigler Z, Lin L, Andrews DF. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr. 1997;21:872-880.
9. Debaere C, Stadnik T, De Maeseneer M, Osteaux M. Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema. Eur Radiol. 1999;9:1916-1918.
10. Shah AK. Cyclosporine A neurotoxicity among bone marrow transplant recipients. Clin Neuropharmacol. 1999;22:67-73.
11. Tezcan H, Zimmer W, Fenstermaker R, Herzig GP, Schriber J. Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK 506. Bone Marrow Transplant. 1998;21:105-109.
12. Weschler D. WAIS-III Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation; 1997.
13. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1985.
14. Reitan RM, Davison LA. Clinical Neuropsychology: Current Status and Applications. Washington, DC: Hemisphere Publishing Corporation; 1974.
15. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1991.
16. Lacy MA, Gore PA Jr, Pliskin NH, Henry GK, Heilbronner RL, Hamer DP. Verbal fluency task equivalence. Clin Neuropsychol. 1996;10:305-308.
17. Gladsjo JA, Schuman CC, Evans JD, Peavy GM, Miller SW, Heaton RK. Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment. 1999;6:147-178.
18. Lezak MD. Neuropsychological Assessment. New York, NY: Oxford University Press; 1995.
19. Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43-55.
20. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual Revised and Expanded. Odessa, FL: Psychological Assessment Resources, 1993.
21. Diggle PJ, Liang K, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press; 2003.
22. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care. 2003;41:582-592.
23. Syrjala KL, Langer SL, Abrams JR, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA. 2004;291:2335-2343.
24. Lee SJ, Fairclough D, Parsons SK, et al. Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol. 2001;19:242-252.
25. Andrykowski MA, Schmitt FA, Gregg ME, Brady MJ, Lamb DG, Henslee-Downey PJ. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer. 1992;70:2288-2297.
26. Saykin A, Ahles T, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsych. 2003;8:201-216.
27. Cimprich B, Ronis DL. An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nurs. 2003;26:284-292.